Evidence map›Paper›PMID 32377369›Full record

ArticleJournal of pharmaceutical health care and sciences2020

Impact of physician-pharmacist collaborative protocol-based pharmacotherapy management for HIV outpatients: a retrospective cohort study.

Kimihiko Urano, Miki Ishibashi, Takeshi Matsumoto, Kohshi Ohishi, Yuichi Muraki, Takuya Iwamoto, Junichi Kunimasa, Masahiro Okuda

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmaceutical health care and sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Investigating the effect of prescribing status and patient characteristics on the therapeutic outcomes in patients with diabetes using a leftover drug adjustment protocol.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Kimihiko Urano1Department of Pharmacy, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Miki Ishibashi1Department of Pharmacy, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Takeshi Matsumoto3Transfusion Medicine and Cell Therapy, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Kohshi Ohishi3Transfusion Medicine and Cell Therapy, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Yuichi Muraki1Department of Pharmacy, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Takuya Iwamoto1Department of Pharmacy, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Junichi Kunimasa2Department of Clinical Pharmacokinetics, School of Pharmacy, Aichi Gakuin University, 1-100, Kusumoto-cho, Chikusa-ku, Nagoya, Aichi 464-8650 Japan.
Masahiro Okuda1Department of Pharmacy, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Mie University Hospital · JPMie University · JPAichi Gakuin University · JPOsaka University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEffective treatment for human immunodeficiency virus (HIV) infection requires close cooperation among healthcare professionals. This is because maintaining continuity with treatment regimens is important in anti-HIV therapy. In addition, explaining medication use is more important than that for other diseases. Since 2010, pharmacists at the Mie University Hospital have been interviewing patients, selecting drugs, and formulating medication plans for HIV-positive patients. In August 2011, we established the physician and pharmacist-led collaborative Protocol-based Pharmacotherapy Management (PBPM) to increase the efficacy and safety of treatment, while reducing the burden on physicians. In the present study, we evaluated the outcomes associated with PBPM for HIV pharmacotherapy.

methodsWe prepared protocols for drug selection, timing of interventions, and methods of intervention according to various guidelines. This study included 40 HIV-positive patients receiving outpatient care between January 2009 and February 2017. Of these patients, 17 received treatment before implementing PBPM and 23 patients received treatment afterward. We compared the intervention parameters between before and after the implementation of PBPM.

resultsThe proportion of patients receiving prescription proposals from pharmacists was markedly higher after introducing PBPM (6 out of 17 patients vs. 23 out of 23 patients). All prescription proposals were accepted by physicians before and after PBPM. The number of interviews before antiretroviral therapy (ART) initiation (median [range]) decreased from 2 [1-5] to 1 [1-3] after PBPM introduction, suggesting the time to introduction of treatment has been shortened. Before the introduction of PBPM, nine patients required a change in their ART prescriptions and four patients were hospitalized (one patient was hospitalized due to an error in the self-administration of anti-HIV medicines, two patients were hospitalized due to interruptions in medication, and one patient was hospitalized for the treatment of other diseases). Only one patient was hospitalized after PBPM, and was unrelated to drug adherence. The proportion of patients with a reduced HIV-RNA load increased from 71 to 100%. Furthermore, the proportion of patients who maintained levels below the limit of quantitation increased from 59 to 91% after implementing PBPM.

conclusionThe implementation of PBPM for HIV outpatients improves the efficacy and safety of HIV pharmacotherapy.

Indexed as

AIDSHIVPBPMPharmacist

Identifiers

PMID32377369
PMCPMC7193403
OpenAlexW3021802462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.